Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | BKCa channels: potential novel anti-migraine target

Messoud Ashina, MD, PhD, DMSc, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, discusses whether direct Large-conductance calcium-activated potassium (BKCa) channel activation can provoke migraine in migraine patients, and whether the BKCa channel could be a potential novel target for its treatment.. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).